{"title":"VCCV: conservative transcriptomic corroboration for measurement prioritization of computational drug-target hypotheses.","authors":"Haihui Huang, Yanan Zhou, Dingkui Kang, Yong Liang","doi":"10.1093/bioinformatics/btag694","DOIUrl":null,"url":null,"abstract":"<p><strong>Motivation: </strong>Computational drug-target interaction (DTI) models nominate plausible binders but cannot determine which candidate best accounts for an observed cellular response. Perturbational transcriptomics offers orthogonal mechanistic evidence, yet pharmacology-to-genetics mismatch, incomplete reference coverage, and non-specific stress programs make simple signature matching unreliable. This motivates a principled integration layer that corroborates hypotheses conservatively, abstains under global mismatch, and prioritizes informative follow-up measurements when the evidence remains ambiguous.</p><p><strong>Results: </strong>We present Virtual-to-Cellular Corroboration for Validation (VCCV), a model-agnostic posterior-triage layer for pre-trained DTI models. VCCV updates calibrated DTI working weights with context-aligned perturbational evidence using a near-identity affine map and exact covariance transport. Within the stated Gaussian class, exact transport is the unique uncertainty update that preserves posterior-odds comparisons under invertible affine changes of measurement coordinates. VCCV also introduces an empirical warning branch for abstention and converts residual ambiguity into compact follow-up gene panels, using a submodular objective for deep near-ties. Each query is assigned one of three actionable states: a target-resolved hypothesis, an abstention, or a prioritized panel. Across five DTI models, VCCV improved discrimination (paired ROC-AUC gains 0.021-0.037) and reduced negative log-likelihood in every case. Additional evaluations showed improved ranking on the same-cell-supported endpoint, warning-score discrimination of strong-response profiles (ROC-AUC 0.876), and better recovery of full-coordinate leading hypotheses by selected panels than by random panels. Across these retrospective kinase-focused evaluations, VCCV provides a principled bridge from computational nomination to conservative, measurement-directed cellular corroboration.</p><p><strong>Availability and implementation: </strong>Source code of VCCV is publicly available at https://github.com/bio-ai-source/VCCV.</p>","PeriodicalId":93899,"journal":{"name":"Bioinformatics (Oxford, England)","volume":" ","pages":""},"PeriodicalIF":5.4000,"publicationDate":"2026-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13633670/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioinformatics (Oxford, England)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/bioinformatics/btag694","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Motivation: Computational drug-target interaction (DTI) models nominate plausible binders but cannot determine which candidate best accounts for an observed cellular response. Perturbational transcriptomics offers orthogonal mechanistic evidence, yet pharmacology-to-genetics mismatch, incomplete reference coverage, and non-specific stress programs make simple signature matching unreliable. This motivates a principled integration layer that corroborates hypotheses conservatively, abstains under global mismatch, and prioritizes informative follow-up measurements when the evidence remains ambiguous.
Results: We present Virtual-to-Cellular Corroboration for Validation (VCCV), a model-agnostic posterior-triage layer for pre-trained DTI models. VCCV updates calibrated DTI working weights with context-aligned perturbational evidence using a near-identity affine map and exact covariance transport. Within the stated Gaussian class, exact transport is the unique uncertainty update that preserves posterior-odds comparisons under invertible affine changes of measurement coordinates. VCCV also introduces an empirical warning branch for abstention and converts residual ambiguity into compact follow-up gene panels, using a submodular objective for deep near-ties. Each query is assigned one of three actionable states: a target-resolved hypothesis, an abstention, or a prioritized panel. Across five DTI models, VCCV improved discrimination (paired ROC-AUC gains 0.021-0.037) and reduced negative log-likelihood in every case. Additional evaluations showed improved ranking on the same-cell-supported endpoint, warning-score discrimination of strong-response profiles (ROC-AUC 0.876), and better recovery of full-coordinate leading hypotheses by selected panels than by random panels. Across these retrospective kinase-focused evaluations, VCCV provides a principled bridge from computational nomination to conservative, measurement-directed cellular corroboration.
Availability and implementation: Source code of VCCV is publicly available at https://github.com/bio-ai-source/VCCV.